Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 201914 results available
- November 20199 results available
- October 201921 results available
- September 201921 results available
- August 201914 results available
- July 201917 results available
- June 201915 results available
- May 20199 results available
- April 201911 results available
- March 201917 results available
- February 20199 results available
- January 20194 results available
Recall class
Displaying 121 - 135 of 161 items.
PMS-Cetirizine tablets (2019-04-26)
RecallHealth product recall | 2019-04-26
Keytruda (2019-04-23)
RecallHealth product recall | 2019-04-23
Centre for Probe Development and Commercialization Products Recall (2019-04-17)
RecallHealth product recall | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Auro-Irbesartan HCT Tablet (2019-04-17)
RecallHealth product recall | 2019-04-17
Ibuprofen tablets (2019-04-16)
RecallHealth product recall | 2019-04-16
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
RecallHealth product recall | 2019-04-12
PMS-Sulfasalazine product recall (2019-04-09)
RecallHealth product recall | 2019-04-09
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
Phenobarb Elixir (2019-03-29)
RecallHealth product recall | 2019-03-29
Neutrarinse 2.0% Caramel (2019-03-26)
RecallHealth product recall | 2019-03-26
Thallous Chloride TI 201 Injection (2019-03-26)
RecallHealth product recall | 2019-03-26
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25